• 1
    Liang MH, Socher SA, Roberts WN, Esdaile JM. Measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum 1988; 31: 81725.
  • 2
    Parodi A, Massone C, Cacciapuoti M, Aragone MG, Bondavalli P, Cattarini G, et al. Measuring the activity of the disease in patients with cutaneous lupus erythematosus. Br J Dermatol 2000; 142: 45760.
  • 3
    Albrecht J, Taylor L, Berlin JA, Dulay S, Ang G, Fakharzadeh S, et al. The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus. J Invest Dermatol 2005; 125: 88994.
  • 4
    Bonilla-Martinez AJ, Taylor L, Okawa J, Werth VP. The CLASI is a useful clinical instrument to separately follow activity and damage during therapy of cutaneous lupus erythematosus. Arch Dermatol In press.
  • 5
    Rothfield N, Sontheimer RD, Bernstein M. Lupus erythematosus: systemic and cutaneous manifestations. Clin Dermatol 2006; 24: 34862.
  • 6
    Tebbe B. Clinical course and prognosis of cutaneous lupus erythematosus. Clin Dermatol 2004; 22: 1214.
  • 7
    Cook DA, Beckman TJ. Current concepts in validity and reliability for psychometric instruments: theory and application. Am J Med 2006; 119: 166e716.
  • 8
    Sontheimer RD. The lexicon of cutaneous lupus erythematosus: a review and personal perspective on the nomenclature and classification of the cutaneous manifestations of lupus erythematosus. Lupus 1997; 6: 8495.
  • 9
    Sellheyer K, Bergfeld WF. A retrospective biopsy study of the clinical diagnostic accuracy of common skin diseases by different specialties compared with dermatology. J Am Acad Dermatol 2005; 52: 82330.
  • 10
    Oranje AP, Stalder JF, Taieb A, Tasset C, de Longueville M, and the Early Treatment of the Atopic Child Study Group. Scoring of atopic dermatitis by SCORAD using a training atlas by investigators from different disciplines. Pediatr Allergy Immunol 1997; 8: 2834.